Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is first to improve or save renal function and second to decrease
cardiac risk factors by optimising the immunosuppressive regimen by withdrawing steroids and
reducing the Cyclosporine A dose. The concomitant administration of Mycophenolatmofetile, an
effective immunosuppressive agent, will minimize the risk of acute rejection episodes.